✦ LIBER ✦

Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-α (IFN-α) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

✍ Scribed by Wassmann, B; Scheuring, U; Pfeifer, H; Binckebanck, A; Käbisch, A; Lübbert, M; Leimer, L; Gschaidmeier, H; Hoelzer, D; Ottmann, O G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy with imatinib mesylate (Glivec)

✍ Gschaidmeier, H; Hoelzer, D; Ottmann, O G; Wassmann, B; Pfeifer, H; Scheuring, U 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

Efficacy of MK-0457 and in combination w

✍ Seiichi Okabe; Tetsuzo Tauchi; Kazuma Ohyashiki 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 338 KB

Efficacy of dasatinib in conjunction wit

✍ Visani, G; Piccaluga, P; Malagola, M; Isidori, A 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

Successful treatment with interferon-α-2

✍ Ichikawa, N; Shimizu, I; Yotsumoto, M; Ueno, M; Sumi, M; Kobayashi, H 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

High-dose imatinib mesylate combined wit

✍ Rea, D; Legros, L; Raffoux, E; Thomas, X; Turlure, P; Maury, S; Dupriez, B; Pign 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Intermediate dose of imatinib in combina

✍ Susana Rives; Jesús Estella; Pedro Gómez; Mónica López-Duarte; Purificación Garc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB